Campus Alert: Find the latest UMMS campus news and resources at

Search Close Search
Page Menu

Robert B Mandell

UMassMed Faculty Page


Title: Human Antibodies Against Rabies and Uses Thereof. UMMS14-48; Patent Pending. 

  • New neutralizing monoclonal antibodies for rabies RAB2 and RAB3. Can be used together or in combination with RAB1, these antibodies have demonstrated superior performance in the treatment of rabies in comparison to other individually tested antibodies and will cover variety of zootonic strains. 


Innovation TopicsBiologicsInfectious DiseasePost-exposure prophylacticRabiesAntibody